CANINSULIN 40 IU/ML SUSPENSION FOR INJECTION
Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Toote omadused
(SPC)
27-02-2015
Mõned selle toote dokumendid pole praegu saadaval. Võite saata päringu meie klienditeenindusele ja me teavitame teid sellest niipea, kui meil on neid võimalik hankida.
Saada päring.
Saada päring.
Toimeaine:
INSULIN PORCINE
Saadav alates:
Intervet Ireland Limited
ATC kood:
QA10AC03
INN (Rahvusvaheline Nimetus):
INSULIN PORCINE
Annus:
40 IU/ML
Ravimvorm:
Suspension for Injection
Retsepti tüüp:
POM
Terapeutiline rühm:
Canine, Feline
Terapeutiline ala:
Insulin (pork)
Näidustused:
Hormone
Volitamisolek:
Authorised
Loa andmise kuupäev:
1997-01-10
Toote omadused
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Caninsulin 40 IU/ml Suspension for Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
A white to almost white suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Caninsulin is indicated in cases of diabetes mellitus (insulin deficiency) in dogs and cats, where the required blood
glucose levels are achieved by using an individually adjusted dose of Caninsulin.
4.3 CONTRAINDICATIONS
Caninsulin is a medium duration insulin and is not intended for the treatment of animals with severe acute diabetes
presenting in a ketoacidotic state. Caninsulin must not be administered by the intravenous route.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In cats diabetic remission may be possible.
Each ml contains:
ACTIVE SUBSTANCE:
Insulin*
40 IU
*(Porcine insulin present as 35% amorphous Zinc insulin and 65% crystalline Zinc insulin)
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 12/02/2015_
_CRN 7020125_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
It is important to establish a strict feeding schedule in consultation with the owner which will include a minimum of
fluctuations and changes. See also information relating to owner precautions under “Maintenance” in section 4.9 The
use of progestagens (oestrus inhibitors) in patients suffering from diabetes mellitus should be avoided.
Ovariohysterectomy may have to be considered. Stress and irregular extra exercise must be avoided. Care must be
taken with the use of corticost
Lugege kogu dokumenti
